News

Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the mRNA COVID vaccine?
HHS phases out mRNA vaccine trials for COVID-19, bird flu
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine priorities.
RFK Jr cancels $500m in funding for mRNA vaccines for diseases like Covid
Health Secretary Robert F Kennedy Jr, a vaccine sceptic, announced he was pulling the funding over claims that "mRNA technology poses more risks than benefits for these respiratory viruses". Doctors and health experts have criticised Kennedy's longstanding questioning of the safety and efficacy of vaccines and his views on health policies.
Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals
Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop funding mRNA drug development.
RFK Jr. announces end to some mRNA contracts, including for flu, covid
The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and anti-vaccine activists.
RFK Jr. is canceling mRNA vaccine development. Can I still get a COVID vaccine?
Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks than benefits. In a video posted on X Aug. 5,
RFK Jr. Cancels $500M in mRNA Vaccine Research Projects
U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development, the agency announced Tuesday.
How RFK Jr.’s mRNA crackdown affects vaccinemaking and future pandemics
The Trump administration is terminating biodefense research funding for mRNA projects, raising concerns about the nation’s ability to fight future pandemics.
RFK Jr. is winding down mRNA vaccine development. What does that mean for vaccines in NY?
Federal vaccine policy changes under RFK Jr. have some concerned health insurance will not cover COVID shots. A bill in NY seeks to mandate coverage.

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Moderna plans to slash 10% of workforce as COVID shot sales slow

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...
Barchart on MSN17h

Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?

Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...

Moderna cuts sales forecast on UK revenue delay, shares fall

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, ...